(S)-4-oxo-2-(2-phenylacetamido)-4-((S)-3-(4-(3-o-tolylureido)benzylcarbamoyl)pyrrolidin-1-yl)butanoic acid

ID: ALA3115406

PubChem CID: 76321533

Max Phase: Preclinical

Molecular Formula: C32H35N5O6

Molecular Weight: 585.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1NC(=O)Nc1ccc(CNC(=O)[C@H]2CCN(C(=O)C[C@H](NC(=O)Cc3ccccc3)C(=O)O)C2)cc1

Standard InChI:  InChI=1S/C32H35N5O6/c1-21-7-5-6-10-26(21)36-32(43)34-25-13-11-23(12-14-25)19-33-30(40)24-15-16-37(20-24)29(39)18-27(31(41)42)35-28(38)17-22-8-3-2-4-9-22/h2-14,24,27H,15-20H2,1H3,(H,33,40)(H,35,38)(H,41,42)(H2,34,36,43)/t24-,27-/m0/s1

Standard InChI Key:  BRGYYPBOMLRWHG-IGKIAQTJSA-N

Molfile:  

     RDKit          2D

 43 46  0  0  0  0  0  0  0  0999 V2000
   22.0208  -22.5932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3232  -23.0108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6041  -22.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9135  -23.0234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1947  -22.6257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5163  -23.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8020  -22.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7905  -21.8217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4908  -21.4024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2038  -21.7975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0767  -21.4244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3742  -21.8450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6654  -21.4539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6554  -20.6449    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9616  -21.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1818  -21.6340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7229  -22.2506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9088  -22.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5251  -21.5002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4758  -22.9116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6641  -22.8863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2771  -22.1670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4663  -22.1359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0818  -21.4199    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0358  -22.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1619  -22.9325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9695  -22.6881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5910  -21.7886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0072  -21.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7161  -21.3573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4409  -21.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4543  -22.5890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7449  -23.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7585  -23.8225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6123  -24.2943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4170  -23.5473    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2311  -23.5760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2183  -22.8027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8378  -22.0753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0078  -22.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5691  -22.7497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9588  -23.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7851  -23.5073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 15 13  1  1
 16 15  1  0
 17 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  1
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 38  1  0
 21 37  1  0
 17 26  1  0
 27 26  1  0
 15 27  1  0
  3 28  2  0
  1 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33  1  1  0
 33 34  1  0
 37 35  2  0
 37 36  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 38  1  0
M  END

Associated Targets(Human)

SK-MEL-24 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 585.66Molecular Weight (Monoisotopic): 585.2587AlogP: 3.31#Rotatable Bonds: 11
Polar Surface Area: 156.94Molecular Species: ACIDHBA: 5HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.74CX Basic pKa: CX LogP: 2.66CX LogD: -0.63
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.23Np Likeness Score: -1.52

References

1. Dattoli SD, De Marco R, Baiula M, Spampinato S, Greco A, Tolomelli A, Gentilucci L..  (2014)  Synthesis and assay of retro-α4β1 integrin-targeting motifs.,  73  [PMID:24412498] [10.1016/j.ejmech.2013.12.009]

Source